Literature DB >> 18508634

Liver receptor homolog-1, an emerging metabolic modulator.

Yoon-Kwang Lee1, David D Moore.   

Abstract

The liver receptor homolog-1 (LRH-1; NR5A2) belongs to nuclear hormone receptor superfamily, and is expressed mainly in the liver, intestine, exocrine pancreas, and ovary. It binds DNA as a monomer, and is best known as a regulator of hepatic expression of the key bile acid biosynthetic enzyme cholesterol 7alpha hydroxylase (Cyp7A1). It is also expressed in embryonic stem cells and the initial stages of embryonic development, and the very early lethality of LRH-1 knockout mice highlights its essential developmental role. Recent crystal structures of LRH-1 and its closest relative steroidogenic factor-1 (SF-1; NR5A1) identified phospholipids as potential ligands. This intriguing discovery raises the possibility of an unexpected new class of nuclear receptor signaling molecules, but the broader functional roles of LRH-1 and these new ligands remain to be established.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508634     DOI: 10.2741/3128

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  46 in total

Review 1.  Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.

Authors:  Thomas P Burris; Scott A Busby; Patrick R Griffin
Journal:  Chem Biol       Date:  2012-01-27

2.  Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation.

Authors:  Paul M Musille; Manish Pathak; Janelle L Lauer; William H Hudson; Patrick R Griffin; Eric A Ortlund
Journal:  Nat Struct Mol Biol       Date:  2012-04-15       Impact factor: 15.369

Review 3.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

4.  LRH-1-dependent glucose sensing determines intermediary metabolism in liver.

Authors:  Maaike H Oosterveer; Chikage Mataki; Hiroyasu Yamamoto; Taoufiq Harach; Norman Moullan; Theo H van Dijk; Eduard Ayuso; Fatima Bosch; Catherine Postic; Albert K Groen; Johan Auwerx; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

5.  New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts.

Authors:  Donghui Li; James L Abbruzzese
Journal:  Clin Cancer Res       Date:  2010-07-20       Impact factor: 12.531

6.  The nuclear hormone receptor family member NR5A2 controls aspects of multipotent progenitor cell formation and acinar differentiation during pancreatic organogenesis.

Authors:  Michael A Hale; Galvin H Swift; Chinh Q Hoang; Tye G Deering; Toshi Masui; Youn-Kyoung Lee; Jumin Xue; Raymond J MacDonald
Journal:  Development       Date:  2014-07-25       Impact factor: 6.868

7.  Metabolism: A lipid for fat disorders.

Authors:  Holly A Ingraham
Journal:  Nature       Date:  2011-06-22       Impact factor: 49.962

8.  LRH-1 and PTF1-L coregulate an exocrine pancreas-specific transcriptional network for digestive function.

Authors:  Sam R Holmstrom; Tye Deering; Galvin H Swift; Frank J Poelwijk; David J Mangelsdorf; Steven A Kliewer; Raymond J MacDonald
Journal:  Genes Dev       Date:  2011-08-15       Impact factor: 11.361

Review 9.  Differentiation of mesenchymal stem cells into gonad and adrenal steroidogenic cells.

Authors:  Takashi Yazawa; Yoshitaka Imamichi; Kaoru Miyamoto; Akihiro Umezawa; Takanobu Taniguchi
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

Review 10.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.